Tufts Postdoc Bridges Computer Science and Alpaca Immunology in Novel Research

Will White, a postdoctoral researcher in Tufts University's Department of Computer Science, has turned his background in bioengineering toward an unexpected partnership with the alpaca immune system. After completing both a bachelor’s and a Ph.D. that centered on molecular biology, White anticipated a career focused on DNA, proteins, and traditional wet‑lab experiments. Instead, his latest work merges algorithmic design with the unique properties of alpaca antibodies, opening a new interdisciplinary frontier.

Alpacas produce a class of single‑chain antibodies known as nanobodies, which are prized for their stability and ease of engineering. White’s project applies machine‑learning techniques to predict nanobody structures and optimize their binding affinities for therapeutic targets. By feeding large datasets of alpaca immune repertoires into computational models, the team aims to accelerate the design cycle that typically requires months of laboratory trial and error.

The initiative reflects a broader trend of computational biology reshaping how researchers approach drug discovery. Traditional methods rely heavily on trial‑and‑error screening of proteins, a process that is both time‑consuming and costly. White’s approach leverages high‑performance computing to simulate interactions at the molecular level, potentially shortening the path from concept to candidate molecule.

University officials note that the collaboration underscores Tufts’ commitment to cross‑departmental research. The computer‑science department provides expertise in algorithm development and data handling, while the bioengineering faculty contributes deep knowledge of immunology and protein chemistry. This synergy allows the project to explore questions that sit at the intersection of two traditionally separate fields.

Looking ahead, White plans to validate his computational predictions through a series of laboratory assays, partnering with biotech firms interested in nanobody therapeutics. If successful, the workflow could serve as a template for applying artificial intelligence to other exotic immune systems, broadening the toolkit available to drug developers. The work not only exemplifies the promise of interdisciplinary science but also highlights how seemingly niche animal biology can inform cutting‑edge technology.